Migraine Headache Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Abortive Medicine, and Preventive Medicine); Route of Administration (Oral, Injection, and Others); Distribution Channel (Hospital-based Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography

Report Code: TIPRE00024005 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Migraine is a clinical condition accompanying painful headaches and other symptoms such as nausea, sensitivity to smell, increased sensitivity to light, increased sensitivity to sound, tingling or numbness in the extremities or legs, sweating, and diarrhea. These headaches usually occur on one side of the head, and each episode of migraine has a different duration and intensity. Migraine drugs are used in the treatment of headaches associated with migraines. Migraines are more frequent in women compared to men.

MARKET SCOPE

The "Global Migraine headache drugs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Migraine headache drugs market with detailed market segmentation by type, route of administration, distribution channel, and geography. The report provides key statistics on the market status of the leading Migraine headache drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

    - Based on type, the global Migraine headache drugs market is segmented into abortive medicine, and preventive medicine. Abortive Medicine is again segmented into triptans (serotonin receptor agonists), ergotamine derivative, others and preventive medicine into anticonvulsant, antidepressant, beta blocker, others.
    - On the basis of route of administration, the market is segmented into oral, injection, others.
    - On the basis of distribution channel, the market is segmented into hospital-based pharmacies, retail pharmacies, online pharmacies.

MARKET DYNAMICS
Drivers:

    - Rise in the cases of migraine.
    - Rise in the awareness regarding migraine and its treatment.
    - Rise in female population.

Restraints:

    - The side effects associated with migraine drugs is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Migraine headache drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

BThe report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Migraine headache drugs market in these regions.

IMPACT OF COVID-19 ON MIGRAINE HEADACHE DRUGS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Migraine headache drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Migraine headache drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for Migraine headache drugs in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Migraine headache drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    - Abbott Laboratories
    - Allergan Plc.
    - AstraZeneca
    - Eisai Co., Ltd.
    - Endo International Plc.
    - GlaxoSmithKline Plc
    - Impax Laboratories
    - Johnson and Johnson
    - Merck and Co.
    - Pfizer Inc.

The Insight Partner's dediMigraine headache drugsed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Migraine Headache Drugs Market - By Type
1.3.2 Migraine Headache Drugs Market - By Route of Administration
1.3.3 Migraine Headache Drugs Market - By Distribution Channel
1.3.4 Migraine Headache Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MIGRAINE HEADACHE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MIGRAINE HEADACHE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MIGRAINE HEADACHE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. MIGRAINE HEADACHE DRUGS - GLOBAL MARKET OVERVIEW
6.2. MIGRAINE HEADACHE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MIGRAINE HEADACHE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ABORTIVE MEDICINE
7.3.1. Overview
7.3.2. Abortive Medicine Market Forecast and Analysis
7.3.3. Triptans (Serotonin Receptor Agonists) Market
7.3.3.1. Overview
7.3.3.2. Triptans (Serotonin Receptor Agonists) Market Forecast and Analysis
7.3.4. Ergotamine Derivative Market
7.3.4.1. Overview
7.3.4.2. Ergotamine Derivative Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. PREVENTIVE MEDICINE
7.4.1. Overview
7.4.2. Preventive Medicine Market Forecast and Analysis
7.4.3. Anticonvulsant Market
7.4.3.1. Overview
7.4.3.2. Anticonvulsant Market Forecast and Analysis
7.4.4. Antidepressant Market
7.4.4.1. Overview
7.4.4.2. Antidepressant Market Forecast and Analysis
7.4.5. Beta Blocker Market
7.4.5.1. Overview
7.4.5.2. Beta Blocker Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
8. MIGRAINE HEADACHE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTION
8.4.1. Overview
8.4.2. Injection Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. MIGRAINE HEADACHE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL-BASED PHARMACIES
9.3.1. Overview
9.3.2. Hospital-based Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. MIGRAINE HEADACHE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Migraine Headache Drugs Market Overview
10.1.2 North America Migraine Headache Drugs Market Forecasts and Analysis
10.1.3 North America Migraine Headache Drugs Market Forecasts and Analysis - By Type
10.1.4 North America Migraine Headache Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Migraine Headache Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Migraine Headache Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Migraine Headache Drugs Market
10.1.6.1.1 United States Migraine Headache Drugs Market by Type
10.1.6.1.2 United States Migraine Headache Drugs Market by Route of Administration
10.1.6.1.3 United States Migraine Headache Drugs Market by Distribution Channel
10.1.6.2 Canada Migraine Headache Drugs Market
10.1.6.2.1 Canada Migraine Headache Drugs Market by Type
10.1.6.2.2 Canada Migraine Headache Drugs Market by Route of Administration
10.1.6.2.3 Canada Migraine Headache Drugs Market by Distribution Channel
10.1.6.3 Mexico Migraine Headache Drugs Market
10.1.6.3.1 Mexico Migraine Headache Drugs Market by Type
10.1.6.3.2 Mexico Migraine Headache Drugs Market by Route of Administration
10.1.6.3.3 Mexico Migraine Headache Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Migraine Headache Drugs Market Overview
10.2.2 Europe Migraine Headache Drugs Market Forecasts and Analysis
10.2.3 Europe Migraine Headache Drugs Market Forecasts and Analysis - By Type
10.2.4 Europe Migraine Headache Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Migraine Headache Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Migraine Headache Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Migraine Headache Drugs Market
10.2.6.1.1 Germany Migraine Headache Drugs Market by Type
10.2.6.1.2 Germany Migraine Headache Drugs Market by Route of Administration
10.2.6.1.3 Germany Migraine Headache Drugs Market by Distribution Channel
10.2.6.2 France Migraine Headache Drugs Market
10.2.6.2.1 France Migraine Headache Drugs Market by Type
10.2.6.2.2 France Migraine Headache Drugs Market by Route of Administration
10.2.6.2.3 France Migraine Headache Drugs Market by Distribution Channel
10.2.6.3 Italy Migraine Headache Drugs Market
10.2.6.3.1 Italy Migraine Headache Drugs Market by Type
10.2.6.3.2 Italy Migraine Headache Drugs Market by Route of Administration
10.2.6.3.3 Italy Migraine Headache Drugs Market by Distribution Channel
10.2.6.4 Spain Migraine Headache Drugs Market
10.2.6.4.1 Spain Migraine Headache Drugs Market by Type
10.2.6.4.2 Spain Migraine Headache Drugs Market by Route of Administration
10.2.6.4.3 Spain Migraine Headache Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Migraine Headache Drugs Market
10.2.6.5.1 United Kingdom Migraine Headache Drugs Market by Type
10.2.6.5.2 United Kingdom Migraine Headache Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Migraine Headache Drugs Market by Distribution Channel
10.2.6.6 Rest of Europe Migraine Headache Drugs Market
10.2.6.6.1 Rest of Europe Migraine Headache Drugs Market by Type
10.2.6.6.2 Rest of Europe Migraine Headache Drugs Market by Route of Administration
10.2.6.6.3 Rest of Europe Migraine Headache Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Migraine Headache Drugs Market Overview
10.3.2 Asia-Pacific Migraine Headache Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Migraine Headache Drugs Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Migraine Headache Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Migraine Headache Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Migraine Headache Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Migraine Headache Drugs Market
10.3.6.1.1 Australia Migraine Headache Drugs Market by Type
10.3.6.1.2 Australia Migraine Headache Drugs Market by Route of Administration
10.3.6.1.3 Australia Migraine Headache Drugs Market by Distribution Channel
10.3.6.2 China Migraine Headache Drugs Market
10.3.6.2.1 China Migraine Headache Drugs Market by Type
10.3.6.2.2 China Migraine Headache Drugs Market by Route of Administration
10.3.6.2.3 China Migraine Headache Drugs Market by Distribution Channel
10.3.6.3 India Migraine Headache Drugs Market
10.3.6.3.1 India Migraine Headache Drugs Market by Type
10.3.6.3.2 India Migraine Headache Drugs Market by Route of Administration
10.3.6.3.3 India Migraine Headache Drugs Market by Distribution Channel
10.3.6.4 Japan Migraine Headache Drugs Market
10.3.6.4.1 Japan Migraine Headache Drugs Market by Type
10.3.6.4.2 Japan Migraine Headache Drugs Market by Route of Administration
10.3.6.4.3 Japan Migraine Headache Drugs Market by Distribution Channel
10.3.6.5 South Korea Migraine Headache Drugs Market
10.3.6.5.1 South Korea Migraine Headache Drugs Market by Type
10.3.6.5.2 South Korea Migraine Headache Drugs Market by Route of Administration
10.3.6.5.3 South Korea Migraine Headache Drugs Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Migraine Headache Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Migraine Headache Drugs Market by Type
10.3.6.6.2 Rest of Asia-Pacific Migraine Headache Drugs Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Migraine Headache Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Migraine Headache Drugs Market Overview
10.4.2 Middle East and Africa Migraine Headache Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Migraine Headache Drugs Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Migraine Headache Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Migraine Headache Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Migraine Headache Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Migraine Headache Drugs Market
10.4.6.1.1 South Africa Migraine Headache Drugs Market by Type
10.4.6.1.2 South Africa Migraine Headache Drugs Market by Route of Administration
10.4.6.1.3 South Africa Migraine Headache Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Migraine Headache Drugs Market
10.4.6.2.1 Saudi Arabia Migraine Headache Drugs Market by Type
10.4.6.2.2 Saudi Arabia Migraine Headache Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Migraine Headache Drugs Market by Distribution Channel
10.4.6.3 U.A.E Migraine Headache Drugs Market
10.4.6.3.1 U.A.E Migraine Headache Drugs Market by Type
10.4.6.3.2 U.A.E Migraine Headache Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Migraine Headache Drugs Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Migraine Headache Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Migraine Headache Drugs Market by Type
10.4.6.4.2 Rest of Middle East and Africa Migraine Headache Drugs Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Migraine Headache Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Migraine Headache Drugs Market Overview
10.5.2 South and Central America Migraine Headache Drugs Market Forecasts and Analysis
10.5.3 South and Central America Migraine Headache Drugs Market Forecasts and Analysis - By Type
10.5.4 South and Central America Migraine Headache Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Migraine Headache Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Migraine Headache Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Migraine Headache Drugs Market
10.5.6.1.1 Brazil Migraine Headache Drugs Market by Type
10.5.6.1.2 Brazil Migraine Headache Drugs Market by Route of Administration
10.5.6.1.3 Brazil Migraine Headache Drugs Market by Distribution Channel
10.5.6.2 Argentina Migraine Headache Drugs Market
10.5.6.2.1 Argentina Migraine Headache Drugs Market by Type
10.5.6.2.2 Argentina Migraine Headache Drugs Market by Route of Administration
10.5.6.2.3 Argentina Migraine Headache Drugs Market by Distribution Channel
10.5.6.3 Rest of South and Central America Migraine Headache Drugs Market
10.5.6.3.1 Rest of South and Central America Migraine Headache Drugs Market by Type
10.5.6.3.2 Rest of South and Central America Migraine Headache Drugs Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Migraine Headache Drugs Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MIGRAINE HEADACHE DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. MIGRAINE HEADACHE DRUGS MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALLERGAN PLC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTRAZENECA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. EISAI CO., LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ENDO INTERNATIONAL PLC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GLAXOSMITHKLINE PLC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. IMPAX LABORATORIES
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. JOHNSON AND JOHNSON
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MERCK AND CO.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PFIZER INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Allergan Plc.
3. AstraZeneca
4. Eisai Co., Ltd.
5. Endo International Plc.
6. GlaxoSmithKline Plc
7. Impax Laboratories
8. Johnson and Johnson
9. Merck and Co.
10. Pfizer Inc.
11. Amgen
12. Teva Pharma
13. Eli Lilly
TIPRE00024005
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking